These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16282404)

  • 1. WHO official warns of crisis in supply of low cost AIDS drugs.
    Zarocostas J
    BMJ; 2005 Nov; 331(7525):1104. PubMed ID: 16282404
    [No Abstract]   [Full Text] [Related]  

  • 2. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 3. Called to account.
    Aldhous P
    Nature; 2004 Jul; 430(6996):133. PubMed ID: 15241382
    [No Abstract]   [Full Text] [Related]  

  • 4. Uganda cuts AIDS drug deal.
    IAPAC Mon; 2001 Feb; 7(2):40. PubMed ID: 11302022
    [No Abstract]   [Full Text] [Related]  

  • 5. Closing the affordability gap for drugs in low-income countries.
    Steinbrook R
    N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV clinics are halting enrolment of new patients as funding stalls, MSF warns.
    Roehr B
    BMJ; 2009 Jul; 339():b2966. PubMed ID: 19620230
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapies. The high cost of poverty.
    Cohen J
    Science; 2002 Jun; 296(5577):2324. PubMed ID: 12089424
    [No Abstract]   [Full Text] [Related]  

  • 8. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustaining treatment costs: who will pay?
    Zewdie D; De Cock K; Piot P
    AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs should be affordable to India's poor to fight HIV/AIDS.
    Agoramoorthy G; Hsu MJ
    AIDS; 2006 Oct; 20(15):1988-9. PubMed ID: 16988526
    [No Abstract]   [Full Text] [Related]  

  • 11. Half the 14 million people in poorer countries who need antiretrovirals get them.
    Gulland A
    BMJ; 2011 Nov; 343():d7576. PubMed ID: 22108274
    [No Abstract]   [Full Text] [Related]  

  • 12. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 13. Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection.
    Maher D; von Schoen-Angerer T; Cohn J
    Int J Clin Pract; 2011 Aug; 65(8):824-7. PubMed ID: 21762306
    [No Abstract]   [Full Text] [Related]  

  • 14. International trade policy and issues of improving access to drugs for HIV/AIDS and other life-threatening and disabling diseases.
    American Public Health Association
    Am J Public Health; 2001 Mar; 91(3):505. PubMed ID: 11236444
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving access to essential drugs for people living with HIV/AIDS.
    Balasubramaniam K
    Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
    [No Abstract]   [Full Text] [Related]  

  • 16. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
    Kazatchkine M; Moatti JP
    Med Sci (Paris); 2008 Dec; 24(12):1007-8. PubMed ID: 19116101
    [No Abstract]   [Full Text] [Related]  

  • 17. [HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
    Med Klin (Munich); 2003 Jul; 98(7):XV-XVI. PubMed ID: 12945544
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug makers to cut prices for developing countries.
    AIDS Alert; 1998 Aug; 13(8 Suppl):1-2. PubMed ID: 11365655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV/AIDS. The great funding surge.
    Cohen J
    Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
    [No Abstract]   [Full Text] [Related]  

  • 20. Companies reduce prices for HIV drugs in developing countries.
    Gottlieb S
    Bull World Health Organ; 2000; 78(6):862. PubMed ID: 10916926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.